The effective shelf creates an overhang that may pressure PDSB shares. Monitor for any takedown announcements or ATM offerings. The company could raise capital at any time, which would dilute existing shareholders.
PDSB drugs
PDSB drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 22 $0.7155entry
- T+1 · 4mo ago −2.10%α −0.86% · $0.7005
- T+5 · 4mo ago −6.42%α −4.01% · $0.6696
- T+20 · 3mo ago −71.95%α −74.85% · $0.2007
- T+60 · 5w ago +81.69%α +78.43% · $1.30
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
PDS Biotechnology Corp's $200M shelf registration (S-3) became effective on 2026-07-21, allowing the company to issue common stock, preferred stock, debt, warrants, units, and rights. Given the company's small market cap (~$43M), this represents substantial potential dilution and overhang on the stock.
Key Facts
- Shelf registration effective on 2026-07-21, File No. 333-297386.
- Authorizes up to $200 million in securities per prior S-3/A filing.
- Market cap approximately $43 million as of filing date.
Financial Impact
Potential dilution up to ~$200M, roughly 4.6x current market cap.
Risk Factors
- Significant dilution risk if the company draws on the shelf.
- Potential stock price pressure from the overhang of unissued shares.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002373 |
| Document: 9999999995-26-002373-index.html | 9999999995-26-002373 |
| Document: 9999999995-26-002373.txt | 9999999995-26-002373 |
Track record
28 reports on PDSB
6 of 13 bullish or bearish reports moved the stock their way by T+20. Best: +67.16% at T+60 after the Jun 15, 2026 report. 10 of 13 went positive at some point.
Filters
- Nov 13, 20263d ago Press Release Neutral 4/10 Entry $0.8726 Now $0.9240 +5.89% settles Dec 14
- Nov 12, 20264d ago SC 13D/A Neutral 4/10 Entry $0.9800 Now $0.9240 −5.71% settles Dec 11
- Nov 10, 20266d ago 8-K Neutral 4/10 Entry $1.03 Now $0.9240 −10.29% settles Dec 9
- Oct 20, 202627d ago 3 Neutral 2/10 Entry $1.24 Now $0.9240 −25.48% settles Nov 18
- Oct 20, 202627d ago 8-K Neutral 4/10 Entry $1.24 Now $0.9240 −25.48% settles Nov 18
- Oct 20, 202627d ago 8-K Neutral 3/10 Entry $0.9605 Now $0.9240 −3.80% settles Nov 17
- Oct 14, 20264w ago S-3 Bearish 7/10 Entry $1.30 to $0.9800 Now $0.9240 +28.92% ▲ +24.62% +22.71% vs SPY
- Oct 6, 20265w ago 8-K Neutral 3/10 Entry $1.05 to $1.41 Now $0.9240 −11.58% ▲ +34.93% +38.10% vs SPY
- Sep 22, 20267w ago 8-K Bullish 6/10 Entry $0.9100 to $0.9605 Now $0.9240 +1.54% ▲ +5.55% +6.11% vs SPY
- Sep 22, 20267w ago Press Release Bullish 7/10 Entry $0.9100 to $0.9605 Now $0.9240 +1.54% ▲ +5.55% +6.11% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers